Intervention: Multi-antigen CMV-Modified Vaccinia Ankara Vaccine
Found 13 matching trials
Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
PHASE2
This randomized phase II trial studies how well multi-antigen cytomegalovir...
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
PHASE2
This phase II clinical trial tests how well the cytomegalovirus-modified va...
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
PHASE2
This randomized phase II trial studies the safety and how well multi-peptid...
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
PHASE1
This phase Ib trial tests the safety, side effects, and how well cytomegalo...
Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma
PHASE1
This phase I trial studies the safety and side effects of cytomegalovirus (...
Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
EARLY_PHASE1
This early phase I trial tests the safety and side effects of allogeneic CM...